AbbVie (ABBV), Allergan (AGN) Merger Cleared by FTC
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Mizuho Securities Reiterates Buy Rating on Abbvie (ABBV) Following US FTC Clearance Announcement
May 6, 2020 7:07 AM EDTMizuho Securities analyst Vamil Divan reiterated a Buy rating and $101.00 price target on Abbvie (NYSE: ABBV) following the company's announcement that they have received US FTC clearance for the Allergan deal. ABBV plans to close the deal this month.
A key concern... More
